Sensorion SA - Asset Resilience Ratio

Latest as of June 2025: 14.20%

Sensorion SA (ALSEN) has an Asset Resilience Ratio of 14.20% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Sensorion SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€10.42 Million

≈ $12.18 Million USD Cash + Short-term Investments

Total Assets

€73.34 Million

≈ $85.74 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Sensorion SA's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Sensorion SA to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sensorion SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Sensorion SA worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€10.42 Million	14.2%
Total Liquid Assets	€10.42 Million	14.20%

Asset Resilience Insights

Moderate Liquidity: Sensorion SA has 14.20% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Sensorion SA Industry Peers by Asset Resilience Ratio

Compare Sensorion SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Hugel Inc KQ:145020	Biotechnology	29.57%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	39.07%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	2.30%
Absci Corp NASDAQ:ABSI	Biotechnology	59.86%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%

Annual Asset Resilience Ratio for Sensorion SA (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Sensorion SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	69.64%	€62.18 Million ≈ $72.69 Million	€89.28 Million ≈ $104.37 Million	+34.24pp
2020-12-31	35.41%	€24.03 Million ≈ $28.09 Million	€67.87 Million ≈ $79.35 Million	+9.15pp
2019-12-31	26.25%	€10.00 Million ≈ $11.69 Million	€38.09 Million ≈ $44.53 Million	+26.08pp
2018-12-31	0.17%	€16.00K ≈ $18.71K	€9.47 Million ≈ $11.07 Million	-85.87pp
2017-12-31	86.04%	€9.60 Million ≈ $11.23 Million	€11.16 Million ≈ $13.05 Million	+14.10pp
2016-12-31	71.94%	€8.53 Million ≈ $9.97 Million	€11.85 Million ≈ $13.86 Million	--

pp = percentage points

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$154.93 Million

€132.52 Million EUR

Market Cap Rank

#17611 Global

#261 in France

Share Price

€0.26

Change (1 day)

+11.47%

52-Week Range

€0.23 - €0.70

All Time High

€12.53